Longevity Acquisition (LOACU) Stock Price, News & Analysis

Company Overview

Longevity Acquisition (OTCMKTS:LOACU) is a special purpose acquisition company incorporated in Delaware in 2021. The company’s primary objective is to identify and complete a business combination with one or more operating businesses in the life sciences and healthcare sectors.

The firm focuses on opportunities in the longevity space, targeting companies developing technologies and therapeutics aimed at extending healthy lifespan, improving age-related health outcomes and addressing chronic conditions associated with aging. Potential targets include biopharmaceutical companies, medical technology innovators and health and wellness service providers.

Longevity Acquisition leverages its management team’s expertise in finance, biotechnology and corporate strategy to source and evaluate acquisition candidates globally. The company’s sponsors have a track record in healthcare investing and aim to create shareholder value through rigorous due diligence and strategic partnership arrangements with target companies.

Since its initial public offering, Longevity Acquisition has maintained an active search for a suitable merger or acquisition partner. The company has up to 24 months to complete a business combination, and its shares trade on the OTC Markets under the ticker symbol LOACU.

Key Stats

• Today's Range: $14.99 to $14.99
• 50-Day Range: $14.99 to $14.99
• 52-Week Range: $11.10 to $20.50
• Volume: N/A
• Average Volume: 440 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LOACU
• CIK: N/A
• Web: N/A
• Phone: 86 21 6083 2028
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A